We are preparing the requested document. Please wait, this may take a while...!
|Application / Reactivity||Human|
|Chromatin Immunoprecipitation (ChIP)||10 Antibodies|
|Dot Blot (DB)||36 Antibodies|
|Electrophoretic Mobility-Shift Assay (EMSA)||2 Antibodies|
|Enzyme Immunoassay (EIA)||10 Antibodies|
|Flow Cytometry (FACS)||73 Antibodies|
|Fluorescence Microscopy (FM)||2 Antibodies|
|Immunochromatography (IC)||10 Antibodies|
|Immunocytochemistry (ICC)||38 Antibodies|
|Immunofluorescence (IF)||113 Antibodies|
|Immunofluorescence (Cultured Cells) (IF (cc))||11 Antibodies|
|Immunofluorescence (Paraffin-embedded Sections) (IF (p))||45 Antibodies|
|Immunohistochemistry (IHC)||203 Antibodies|
|Immunohistochemistry (Acetone-fixed) (IHC (af))||7 Antibodies|
|Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))||6 Antibodies|
|Immunohistochemistry (Frozen Sections) (IHC (fro))||27 Antibodies|
|Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))||97 Antibodies|
|Antigen||V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) Antibodies|
|Conjugate||This C-MYC antibody is un-conjugated Alternatives|
Fluorescence Microscopy (FM), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
|13 references available|
|Supplier||Log in to see|
Product Details anti-C-MYC AntibodyTarget Details C-MYC Application Details Handling References for anti-C-MYC Antibody (ABIN967319) Images
1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Please refer to us for technical protocols.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
4. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
|Purification||The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.|
|Immunogen||Human c-Myc Peptide|
Target Details C-MYCProduct Details anti-C-MYC Antibody Application Details Handling References for anti-C-MYC Antibody (ABIN967319) Images back to top
|Alternative Name||c-Myc (MYC Antibody Abstract)|
|Background||The myc gene family contains at least seven closely related genes, c-myc, N-myc, L-myc, P-myc, R-myc, S-myc, and B-myc. C-myc plays a role in proliferation, transformation, and differentiation. It is expressed during embryonic development, in a wide variety of adult tissues, and is amplified in many tumors, particularly lung, breast, cervical and colon carcinomas. Cellular localization has been described as nuclear and/or cytopasmic. C-myc has three sequence motifs in the carboxy terminus, a leucine zipper, a helix-loop-helix, and a basic region. It forms sequence-specific (CACGTG) DNA binding heterodimers with max, a helixloop-helix/leucine zipper protein. Both the leucine zipper domain and the helixloop-helix motif of c-myc contribute to heterodimer formation. DNA binding of myc-max dimers results in a conformational change of the DNA and transcriptional activation. C-myc migrates at 62 kDa in SDS-PAGE. Clone 9E10 recognizes human c-myc. A synthetic peptide corresponding to a C-terminal epitope of the human c-myc protein (AEEQKLISEEDL) was used as an immunogen.|
|Research Area||Cancer, Cell Cycle, Transcription Factors|
|Pathways||p53 Signaling, Cell Division Cycle|
Application DetailsProduct Details anti-C-MYC Antibody Target Details C-MYC Handling References for anti-C-MYC Antibody (ABIN967319) Images back to top
|Application Notes||It is particularly useful for western blot analysis of myc-tagged recombinant proteins, and recombinant c-myc. Jurkat control lysate [50 µg (1 µg/µl)] is provided as a western blot positive control (store lysate at -20 °C). Additional control lysate is sold separately.|
Related Products: ABIN968537, ABIN967389
|Restrictions||For Research Use only|
HandlingProduct Details anti-C-MYC Antibody Target Details C-MYC Application Details References for anti-C-MYC Antibody (ABIN967319) Images back to top
|Buffer||Aqueous buffered solution containing BSA, glycerol, and ≤0.09 % sodium azide.|
|Precaution of Use||This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.|
|Storage Comment||Store undiluted at -20° C.|
References for anti-C-MYC Antibody (ABIN967319)Product Details anti-C-MYC Antibody Target Details C-MYC Application Details Handling Images back to top
Liu, Hsu, Goeddel et al.: "Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death." in: Cell, Vol. 87, Issue 3, pp. 565-76, 1996 (PubMed).
Lukas, Parry, Aagaard et al.: "Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16." in: Nature, Vol. 375, Issue 6531, pp. 503-6, 1995 (PubMed).
Evan, Lewis, Ramsay et al.: "Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product." in: Molecular and cellular biology, Vol. 5, Issue 12, pp. 3610-6, 1986 (PubMed).
Spandidos, Yiagnisis, Papadimitriou et al.: "ras, c-myc and c-erbB-2 oncoproteins in human breast cancer." in: Anticancer research, Vol. 9, Issue 5, pp. 1385-93, 1990 (PubMed).
Tiniakos, Spandidos, Kakkanas et al.: "Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues." in: Anticancer research, Vol. 9, Issue 3, pp. 715-21, 1989 (PubMed).
Karayiannis, Yiagnisis, Papadimitriou et al.: "Evaluation of the ras and myc oncoproteins in benign gastric lesions." in: Anticancer research, Vol. 10, Issue 5A, pp. 1127-33, 1990 (PubMed).
Williams, Piris, Wyllie: "Immunohistochemical demonstration of altered intracellular localization of the C-Myc oncogene product in human colorectal neoplasms." in: The Journal of pathology, Vol. 160, Issue 4, pp. 287-93, 1990 (PubMed).
Gosney, Field, Gosney et al.: "c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types." in: Anticancer research, Vol. 10, Issue 3, pp. 623-8, 1990 (PubMed).
Blackwood, Eisenman: "Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc." in: Science (New York, N.Y.), Vol. 251, Issue 4998, pp. 1211-7, 1991 (PubMed).
DePinho, Schreiber-Agus, Alt: "myc family oncogenes in the development of normal and neoplastic cells." in: Advances in cancer research, Vol. 57, pp. 1-46, 1991 (PubMed).
Tosca, Linardopoulos, Malliri et al.: "Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides." in: Anticancer research, Vol. 11, Issue 4, pp. 1433-8, 1992 (PubMed).
Campbell, Kessler, Fambrough: "The alternative carboxyl termini of avian cardiac and brain sarcoplasmic reticulum/endoplasmic reticulum Ca(2+)-ATPases are on opposite sides of the membrane." in: The Journal of biological chemistry, Vol. 267, Issue 13, pp. 9321-5, 1992 (PubMed).
Royds, Sharrard, Wagner et al.: "Cellular localisation of c-myc product in human colorectal epithelial neoplasia." in: The Journal of pathology, Vol. 166, Issue 3, pp. 225-33, 1992 (PubMed).
ImagesProduct Details anti-C-MYC Antibody Target Details C-MYC Application Details Handling References for anti-C-MYC Antibody (ABIN967319) back to top